Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06615453 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease

Study acronym: TIXEL-DED
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 26, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary and study completion dates: Sep 2025 to Jul 31, 2026v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will examine how a standard Tixel treatment versus a sham treatment for eye wrinkles affects the symptoms and signs of Dry Eye Disease.
Trial Details
NCT Number NCT06615453
Lead Sponsor Aston University
Conditions
(from sponsor)		 Dry Eye Disease (DED)
Related terms Dry Eye Syndromes
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov